- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ipilimumab and nivolumab
Total 271195 results
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerItaly, United States, Argentina, Belgium, Germany, Israel, Poland, Spain, Turkey, Australia, Chile, France
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
University of California, IrvineExelixisRecruitingHCC | Hepatocellular CarcinomaUnited States
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Jounce Therapeutics, Inc.Completed
-
Sarcoma Oncology Research Center, LLCBristol-Myers SquibbRecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingColon CarcinomaNetherlands
-
ArdigenMałopolskie Centre of EntrepreneurshipUnknownNon Small Cell Lung Cancer | Immunotherapy | Neoantigens | Neoepitopes | Next Generation Sequencing (NGS) | Personalized Neoantigen Cancer VaccinePoland
-
Takara Bio Inc.TheradexCompletedMalignant MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Hoffmann-La RocheCompletedMelanomaUnited States, Italy, Australia, France, Spain, Netherlands
-
Takayuki YoshinoOno Pharmaceutical Co. LtdRecruiting
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruitingMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
University of FloridaNational Center for Complementary and Integrative Health (NCCIH)TerminatedObesity | Oxidative StressUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular CarcinomaUnited States, Singapore, Spain, United Kingdom, Germany, Italy, Canada, France, Hong Kong, Japan, Korea, Republic of, Puerto Rico, Taiwan
-
University of Alabama at BirminghamWithdrawnCarcinosarcoma of Ovary | Carcinosarcoma of Uterus | Carcinosarcoma of VaginaUnited States
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbTerminatedNeuroendocrine Tumors | Carcinoid TumorUnited States
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
MacroGenicsCompletedMelanoma | Non Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingRenal Cell CarcinomaUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid MalignanciesUnited States
-
PfizerCompletedLung NeoplasmsUnited States, Canada, Ireland, United Kingdom, Italy, Germany, Spain, Netherlands
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology... and other collaboratorsSuspended
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Roberto PiliBristol-Myers Squibb; Syndax Pharmaceuticals; Indiana University School of MedicineActive, not recruitingRenal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedDiffuse Glioma | Secondary Glioblastoma | Glioblastoma, IDH-Wildtype | Astrocytoma, IDH-Mutant, Grade 4United States, Puerto Rico
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
ArdigenNational Center for Research and Development, PolandUnknownMelanoma | Non Small Cell Lung Cancer | Metagenome | Immunotherapy | MicrobiomePoland
-
Abramson Cancer Center at Penn MedicineTerminatedRenal Cell Carcinoma | Renal Cell Carcinoma Stage IVUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrothelial CancerRussian Federation, United States, Brazil, Spain, Chile, Korea, Republic of, Argentina, Australia, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Poland, Romania, Swed... and more
-
Jeffrey ClarkeCompletedNon-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer InstituteWithdrawnMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Brown UniversityBristol-Myers Squibb; The Miriam Hospital; Rhode Island Hospital; Women and Infants...Terminated
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...Active, not recruitingNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic DiseaseAustralia
-
Incyte CorporationTerminated
-
Scott AntoniaRecruitingLung Cancer MetastaticUnited States
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
Amsterdam UMC, location VUmcMedarex; Cell GenesysTerminatedProstate CancerNetherlands
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
Emory UniversityGenentech, Inc.Active, not recruitingStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Unresectable Melanoma | Stage III Melanoma | Stage IIIA Skin Melanoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IVUnited States